SBX.DU SynBiotic SE
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- 0.2/5
Ratios use the latest price and the fiscal year ending Dec 2022.
Is SBX.DU undervalued?
Graham numberThe Graham number of SynBiotic SE cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SynBiotic SE fundamental analysis
1 of 21 checks passedROE 0/2
ROE cannot be calculated: equity is negative or not reported.
ROA 0/1
Return on assets cannot be compared with the industry.
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Earnings growth cannot be compared with the industry.
Revenue Growth 0/2
Revenue did not grow over the past 3 years or is not reported.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 0/2
Cash runway cannot be calculated.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book is negative or not available.
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
SynBiotic SE stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SynBiotic SE
SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe. It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products. The company was incorporated in 2024 and is based in Düsseldorf, Germany.
Full company profileSynBiotic SE financial statements
SynBiotic SE annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Cash Flow | ||||
| Operating Cash Flow | -11.4K | -1.26M | -5.14M | -7.00M |
| Capital Expenditure | 17.8K | 17.8K | 366K | 278K |
What these items mean
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
SynBiotic SE dividends
SynBiotic SE has not paid dividends in the last 5 fiscal years.
Who owns SynBiotic SE
Ownership data of SynBiotic SE is not available yet.
SynBiotic SE company profile
- Company name
- SynBiotic SE
- Ticker
- SBX.DU
- ISIN
- DE000A3E5A59
- Exchange
- Dusseldorf Exchange
- Sector
- Healthcare
- Industry
- Oil, Gas & Consumable Fuels
- Employees
- 79
- Fiscal year end
- December
- Address
- Münsterstraße 336, Düsseldorf, Germany, 40470
- Website
- synbiotic.com
About SynBiotic SE
SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe. It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products. The company was incorporated in 2024 and is based in Düsseldorf, Germany.
SynBiotic SE management
2- Mr. Daniel KruseMD & Director
- Ms. Rebecca Kruse-Rosetti?Head of Finance